SV2011003785A - Nuevas posibilidades de lucha contra la giardiasis - Google Patents
Nuevas posibilidades de lucha contra la giardiasisInfo
- Publication number
- SV2011003785A SV2011003785A SV2011003785A SV2011003785A SV2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A
- Authority
- SV
- El Salvador
- Prior art keywords
- fight against
- new possibilities
- giardiasis
- against giardiasis
- possibilities
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Catching Or Destruction (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE AL USO DE NIFURTIMOX PARA EL TRATAMIENTO DE GIARDIASIS, EN PARTICULAR EN PERROS Y GATOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008031284A DE102008031284A1 (de) | 2008-07-02 | 2008-07-02 | Neue Bekämpfungsmöglichkeit der Giardiose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2011003785A true SV2011003785A (es) | 2011-05-20 |
Family
ID=41077987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2011003785A SV2011003785A (es) | 2008-07-02 | 2011-01-03 | Nuevas posibilidades de lucha contra la giardiasis |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8440612B2 (es) |
| EP (1) | EP2310018B1 (es) |
| JP (1) | JP5627579B2 (es) |
| KR (1) | KR101720805B1 (es) |
| CN (1) | CN102083441B (es) |
| AR (1) | AR072425A1 (es) |
| AU (1) | AU2009266125B2 (es) |
| BR (1) | BRPI0913889B1 (es) |
| CA (1) | CA2729730C (es) |
| CL (2) | CL2010001577A1 (es) |
| CO (1) | CO6321270A2 (es) |
| CR (1) | CR20110022A (es) |
| DE (1) | DE102008031284A1 (es) |
| DK (1) | DK2310018T3 (es) |
| DO (1) | DOP2010000405A (es) |
| EC (1) | ECSP10010720A (es) |
| ES (1) | ES2444581T3 (es) |
| IL (1) | IL209698A (es) |
| MX (1) | MX2010014446A (es) |
| MY (1) | MY157007A (es) |
| NI (1) | NI201100008A (es) |
| NZ (1) | NZ590276A (es) |
| PE (1) | PE20110283A1 (es) |
| PL (1) | PL2310018T3 (es) |
| RU (1) | RU2538713C9 (es) |
| SV (1) | SV2011003785A (es) |
| UA (1) | UA103328C2 (es) |
| WO (1) | WO2010000399A1 (es) |
| ZA (1) | ZA201009225B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012051251A1 (en) * | 2010-10-12 | 2012-04-19 | The Usa, As Repr. By The Secrt, Dept. Of Health & Human Serv. Office Of Technology Transfer, | Methods of treating giardiasis |
| SMT202100417T1 (it) | 2015-05-20 | 2021-09-14 | Boehringer Ingelheim Animal Health Usa Inc | Composti depsipeptidici antielmintici |
| AU2016380868B2 (en) | 2015-12-28 | 2019-11-28 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic depsipeptide compounds |
| CN110167921A (zh) | 2016-11-16 | 2019-08-23 | 勃林格殷格翰动物保健美国公司 | 驱蠕虫缩肽化合物 |
| EP3750527A1 (en) * | 2019-06-13 | 2020-12-16 | Bayer AG | Stable tablet formulation of nifurtimox and process for producing the same |
| CN114377018B (zh) * | 2020-10-21 | 2024-02-06 | 中国医学科学院药物研究所 | 硝呋莫司在制备抗流感病毒药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1170957B (de) * | 1962-11-23 | 1964-05-27 | Bayer Ag | Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten |
| JPH081908B2 (ja) * | 1987-07-22 | 1996-01-10 | 三菱電機株式会社 | 超格子半導体素子 |
| NO176766C (no) | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
| DE69331414T2 (de) | 1992-03-17 | 2002-08-08 | Fujisawa Pharmaceutical Co., Ltd. | Depsipeptide, herstellung und anwendung |
| DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
| KR100309091B1 (ko) | 1993-02-19 | 2001-12-28 | 이치로 키타사토 | 환상 데프시펩티드 pf 1022의 유도체 |
| DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| DE4317432A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| DE69430128T2 (de) | 1993-09-06 | 2002-09-05 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide |
| DE4401389A1 (de) | 1994-01-19 | 1995-07-20 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung |
| DE4406025A1 (de) | 1994-02-24 | 1995-08-31 | Bayer Ag | Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung |
| DE4437198A1 (de) | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
| WO1997002256A1 (fr) | 1995-06-30 | 1997-01-23 | Fujisawa Pharmaceutical Co., Ltd. | Derive depsipeptidique, son procede de production et son nouvel intermediaire |
| KR19990063676A (ko) | 1995-09-22 | 1999-07-26 | 빌프리더 하이더 | 신규한 환상 데프시펩티드 pf1022 유도체 |
| DE19545639A1 (de) | 1995-12-07 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US5874630A (en) * | 1998-01-06 | 1999-02-23 | Occidental Chemical Corporation | Synthesis of mercaptans from alcohols |
| US6133228A (en) * | 1998-05-28 | 2000-10-17 | Firmenich Sa | Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters |
| DE19828047A1 (de) * | 1998-06-24 | 1999-12-30 | Bayer Ag | Substituierte Cyclooctadepsipeptide |
| WO2006053160A2 (en) * | 2004-11-12 | 2006-05-18 | Celgene Corporation | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| DE102005033496A1 (de) | 2005-07-19 | 2007-01-25 | Bayer Healthcare Ag | Desinfektionsmittel |
-
2008
- 2008-07-02 DE DE102008031284A patent/DE102008031284A1/de not_active Withdrawn
-
2009
- 2009-06-20 UA UAA201101135A patent/UA103328C2/uk unknown
- 2009-06-20 NZ NZ590276A patent/NZ590276A/xx not_active IP Right Cessation
- 2009-06-20 DK DK09772099.9T patent/DK2310018T3/da active
- 2009-06-20 ES ES09772099.9T patent/ES2444581T3/es active Active
- 2009-06-20 PE PE2010001201A patent/PE20110283A1/es not_active Application Discontinuation
- 2009-06-20 CN CN2009801255081A patent/CN102083441B/zh not_active Expired - Fee Related
- 2009-06-20 WO PCT/EP2009/004475 patent/WO2010000399A1/de active Application Filing
- 2009-06-20 KR KR1020117002111A patent/KR101720805B1/ko not_active Expired - Fee Related
- 2009-06-20 RU RU2011103475/15A patent/RU2538713C9/ru not_active IP Right Cessation
- 2009-06-20 AU AU2009266125A patent/AU2009266125B2/en not_active Ceased
- 2009-06-20 JP JP2011515179A patent/JP5627579B2/ja not_active Expired - Fee Related
- 2009-06-20 BR BRPI0913889A patent/BRPI0913889B1/pt not_active IP Right Cessation
- 2009-06-20 MX MX2010014446A patent/MX2010014446A/es active IP Right Grant
- 2009-06-20 CA CA2729730A patent/CA2729730C/en not_active Expired - Fee Related
- 2009-06-20 PL PL09772099T patent/PL2310018T3/pl unknown
- 2009-06-20 US US13/000,715 patent/US8440612B2/en not_active Expired - Fee Related
- 2009-06-20 MY MYPI2010006319A patent/MY157007A/en unknown
- 2009-06-20 EP EP09772099.9A patent/EP2310018B1/de not_active Not-in-force
- 2009-06-30 AR ARP090102439A patent/AR072425A1/es not_active Application Discontinuation
-
2010
- 2010-12-01 IL IL209698A patent/IL209698A/en active IP Right Grant
- 2010-12-22 ZA ZA2010/09225A patent/ZA201009225B/en unknown
- 2010-12-27 CO CO10162857A patent/CO6321270A2/es active IP Right Grant
- 2010-12-27 CL CL2010001577A patent/CL2010001577A1/es unknown
- 2010-12-27 EC EC2010010720A patent/ECSP10010720A/es unknown
- 2010-12-27 DO DO2010000405A patent/DOP2010000405A/es unknown
-
2011
- 2011-01-03 SV SV2011003785A patent/SV2011003785A/es active IP Right Grant
- 2011-01-05 NI NI201100008A patent/NI201100008A/es unknown
- 2011-01-11 CR CR20110022A patent/CR20110022A/es unknown
-
2013
- 2013-03-15 CL CL2013000709A patent/CL2013000709A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2009003098A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
| CO6731068A2 (es) | Arilpirrolodonas pesticidas | |
| BRPI0912431A2 (pt) | Combinações de substâncias ativas sinergísticas | |
| BRPI0924425A2 (pt) | "combinações de substâncias ativas sinergéticas". | |
| MX349796B (es) | Composiciones farmacéuticas para usarse en el tratamiento de trastornos oncológicos mediante el uso de coenzima q10. | |
| BRPI1011655A2 (pt) | uso de lcat para tratar anemia e disfunção de glóbulos vermelhos | |
| BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
| CL2008002893A1 (es) | Compuestos derivados de n-fenil-(piridin-3-il) acetamida sustituidas; composicion farmaceutica; procedimiento de preparacion; y su uso para prevenir o tratar el cancer. | |
| BRPI0807487A2 (pt) | Uso de antagonistas de il-23 para o tratamento de infecção | |
| ES2525801T8 (es) | Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes | |
| CL2009001484A1 (es) | Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia. | |
| BRPI0911031B8 (pt) | compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes | |
| NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
| BR112012028719A2 (pt) | composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação | |
| BR112012029746A2 (pt) | composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação | |
| BRPI0908428A2 (pt) | uso de ranozalina para tratar a dor. | |
| CL2011002548A1 (es) | Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica. | |
| ECSP109923A (es) | Bromhidrato de bupropion y aplicaciones terapéuticas | |
| BRPI0819105A2 (pt) | composição para o tratamento e prevenção de edema de pálpebra | |
| ES2399651T8 (es) | Utilización de pasireotida para el tratamiento de la hipoglucemia hiperinsulenémica endógena | |
| BRPI0910359A2 (pt) | método para inibir o crescimento de microorganismos e composição biocida | |
| SV2011003785A (es) | Nuevas posibilidades de lucha contra la giardiasis | |
| BR112014009456A2 (pt) | uso de melatonina para o tratamento e/ou prevenção de mucosite | |
| CO6801728A2 (es) | Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis | |
| BRPI0912890A2 (pt) | composição farmacêutica para o tratamento de ejaculação precoce |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant | ||
| FG | Grant |